91 related articles for article (PubMed ID: 3566548)
1. [Histochemical characteristics of renal cell cancer].
Shliapnikov VV
Arkh Patol; 1986; 48(12):53-7. PubMed ID: 3566548
[TBL] [Abstract][Full Text] [Related]
2. [The degree of malignancy and histologic variants of kidney cancer: their importance in diagnosis and prognosis].
Shlopov VG; Vlodavskiĭ EA; Tikhonova VI
Arkh Patol; 1988; 50(10):21-7. PubMed ID: 3219083
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of the histological variants of renal cell cancer].
Loginov VA; Kuznetsov SV
Arkh Patol; 1985; 47(10):16-24. PubMed ID: 4074137
[TBL] [Abstract][Full Text] [Related]
4. [Enzyme histochemical characteristics of the variants of kidney cancer].
Shliapnikov VV; Raĭkhlin NT; Vasil'eva NN; Zhukotskiĭ AV
Arkh Patol; 1988; 50(7):58-63. PubMed ID: 2847692
[TBL] [Abstract][Full Text] [Related]
5. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
6. Absence or reduction of Fhit expression in most clear cell renal carcinomas.
Hadaczek P; Siprashvili Z; Markiewski M; Domagala W; Druck T; McCue PA; Pekarsky Y; Ohta M; Huebner K; Lubinski J
Cancer Res; 1998 Jul; 58(14):2946-51. PubMed ID: 9679951
[TBL] [Abstract][Full Text] [Related]
7. Renal cell carcinoma in the Wistar-Lewis rat: a model for studying the mechanisms of cholesterol acquisition by a tumor in vivo.
Clayman RV; Bilhartz LE; Buja LM; Spady DK; Dietschy JM
Cancer Res; 1986 Jun; 46(6):2958-63. PubMed ID: 3486039
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Kuehn A; Paner GP; Skinnider BF; Cohen C; Datta MW; Young AN; Srigley JR; Amin MB
Am J Surg Pathol; 2007 Oct; 31(10):1528-33. PubMed ID: 17895753
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma].
Tan WL; Xiong L; Zheng SB; Yu ZC; Qi H; Du YJ; Wu P
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1316-8. PubMed ID: 16982445
[TBL] [Abstract][Full Text] [Related]
10. Metastatic renal cell carcinoma to the bladder: a clinicopathologic and immunohistochemical study.
Sim SJ; Ro JY; Ordonez NG; Park YW; Kee KH; Ayala AG
Mod Pathol; 1999 Apr; 12(4):351-5. PubMed ID: 10229498
[TBL] [Abstract][Full Text] [Related]
11. Renal cell carcinoma with rhabdoid features. Divergent differentiation of conventional (clear cell) carcinoma.
Klimis T; Karvounis H
J BUON; 2008; 13(3):433-6. PubMed ID: 18979563
[TBL] [Abstract][Full Text] [Related]
12. Enzyme activity and protein content of superoxide dismutase isozymes in human renal cell carcinoma.
Homma-Takeda S; Sasaki A; Kikushima M; Kumagai Y; Uchida K; Kawai K; Akaza H; Shimojo N
Res Commun Mol Pathol Pharmacol; 2000; 108(1-2):49-55. PubMed ID: 11758974
[TBL] [Abstract][Full Text] [Related]
13. [Papillary renal cell carcinoma: clinico-pathologic studies of 33 cases].
Liu LN; Chen GY; Wang P; Zhang CH; Huang SF
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):102-5. PubMed ID: 15946550
[TBL] [Abstract][Full Text] [Related]
14. [Expression of TFAR19(PDCD5) in normal human kidney, renal clear cell carcinoma, normal human bladder and bladder carcinoma].
Xiong L; Tan WL; Yu ZC; Wu YD; Huang H; Zhao GZ; Zhu WH; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):805-9. PubMed ID: 16793605
[TBL] [Abstract][Full Text] [Related]
15. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.
Byun SS; Yeo WG; Lee SE; Lee E
Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609
[TBL] [Abstract][Full Text] [Related]
16. Primary thyroid-like follicular carcinoma of the kidney: report of 6 cases of a histologically distinctive adult renal epithelial neoplasm.
Amin MB; Gupta R; Ondrej H; McKenney JK; Michal M; Young AN; Paner GP; Junker K; Epstein JI
Am J Surg Pathol; 2009 Mar; 33(3):393-400. PubMed ID: 19047894
[TBL] [Abstract][Full Text] [Related]
17. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
Rodins K; Cheale M; Coleman N; Fox SB
Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
[TBL] [Abstract][Full Text] [Related]
18. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype.
Swiercz R; Wolfe JD; Zaher A; Jankun J
Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880
[TBL] [Abstract][Full Text] [Related]
19. Expression of the multiple drug resistance gene in human renal cell carcinoma depends on tumor histology, grade, and stage.
Tobe SW; Noble-Topham SE; Andrulis IL; Hartwick RW; Skorecki KL; Warner E
Clin Cancer Res; 1995 Dec; 1(12):1611-5. PubMed ID: 9815963
[TBL] [Abstract][Full Text] [Related]
20. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
